1. Home
  2. MIRM vs SEATW Comparison

MIRM vs SEATW Comparison

Compare MIRM & SEATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • SEATW
  • Stock Information
  • Founded
  • MIRM 2018
  • SEATW 2001
  • Country
  • MIRM United States
  • SEATW United States
  • Employees
  • MIRM N/A
  • SEATW 768
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • SEATW Industrial Machinery/Components
  • Sector
  • MIRM Health Care
  • SEATW Industrials
  • Exchange
  • MIRM Nasdaq
  • SEATW Nasdaq
  • Market Cap
  • MIRM 1.9B
  • SEATW N/A
  • IPO Year
  • MIRM 2019
  • SEATW N/A
  • Fundamental
  • Price
  • MIRM $39.43
  • SEATW $0.25
  • Analyst Decision
  • MIRM Strong Buy
  • SEATW
  • Analyst Count
  • MIRM 11
  • SEATW 0
  • Target Price
  • MIRM $58.55
  • SEATW N/A
  • AVG Volume (30 Days)
  • MIRM 437.5K
  • SEATW 2.3K
  • Earning Date
  • MIRM 05-07-2025
  • SEATW 03-04-2025
  • Dividend Yield
  • MIRM N/A
  • SEATW N/A
  • EPS Growth
  • MIRM N/A
  • SEATW N/A
  • EPS
  • MIRM N/A
  • SEATW N/A
  • Revenue
  • MIRM $336,888,000.00
  • SEATW $774,076,000.00
  • Revenue This Year
  • MIRM $29.51
  • SEATW N/A
  • Revenue Next Year
  • MIRM $20.27
  • SEATW N/A
  • P/E Ratio
  • MIRM N/A
  • SEATW $15.73
  • Revenue Growth
  • MIRM 80.76
  • SEATW 13.91
  • 52 Week Low
  • MIRM $23.14
  • SEATW $0.13
  • 52 Week High
  • MIRM $54.23
  • SEATW $1.59
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 38.25
  • SEATW 56.11
  • Support Level
  • MIRM $38.22
  • SEATW $0.19
  • Resistance Level
  • MIRM $39.87
  • SEATW $0.22
  • Average True Range (ATR)
  • MIRM 2.41
  • SEATW 0.01
  • MACD
  • MIRM -0.16
  • SEATW 0.01
  • Stochastic Oscillator
  • MIRM 29.04
  • SEATW 100.00

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About SEATW Vivid Seats Inc. Warrant

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: